In a new development, men may soon be able to equitably share the responsibility of avoiding pregnancy along with their partners as YCT-529, a birth control experimental pill has passed its initial ...
YCT-529 inhibits retinoic acid receptor alpha to suppress sperm production reversibly. Currently in Phase 1b/2a trials, the compound has shown promise in preclinical models and aims to expand ...
A drug candidate called YCT-529, which creator YourChoice Therapeutics is angling to make the first non-hormonal contraceptive pill for men, entered its Phase 1 clinical trial on December 13 in the ...
A revolutionary step in reproductive health may soon change the way contraception is shared between partners. The non-hormonal male contraceptive pill YCT-529 has recently passed its first phase of ...
Add Yahoo as a preferred source to see more of our stories on Google. The Texas State Capitol Building at sunset in Austin, Texas Image by Lucky-photographerShutterstock (1) The Young Conservatives of ...
YCT-529, a groundbreaking hormone-free male contraceptive pill, has successfully completed its first human safety trial, marking a significant advancement in reproductive health. Unlike traditional ...